A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders Protocol#6901
Sponsor: |
NIH |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAT3857 |
U.S. Govt. ID: |
NCT01186913 |
Contact: |
Olatundun Williams, MD: / ow2188@cumc.columbia.edu |
This study is being done to identify the best outcomes for hematopoietic cell transplantation (HCT) or other treatment (enzyme replacement or gene therapy), which is life-saving therapy for children with SCID (severe combined immunodeficiency), leaky SCID, Omenn syndrome and reticular dysgenesis.
This study is closed
Investigator
Olatundun Williams, MD
Is your child under 18 years old? |
Yes |
No |
Does your child have SCID (Severe Combined Immunodeficiency)? |
Yes |
No |